{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T15:54:07Z","timestamp":1732031647333},"reference-count":26,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,4,11]],"date-time":"2005-04-11T00:00:00Z","timestamp":1113177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Microbiology and Immunology"],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Oral warts, caused by human papillomavirus (HPV), and oral hairy leukoplakia (OHL) caused by Epstein\u2010Barr virus (EBV), are common oral manifestations in HIV\u2010infected persons. Although both conditions occur most often with reduced blood CD4<jats:sup>+<\/jats:sup> T\u2010cell numbers, oral warts and OHL rarely occur simultaneously, suggesting that dysfunctions in other secondary local immune parameters are also involved. The present study evaluated tissue\u2010associated proinflammatory and T\u2010helper cytokine and chemokine mRNA expression and the presence of T cells in each lesion.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Biopsies were taken from lesion\u2010positive and adjacent lesion\u2010negative sites of HIV<jats:sup>+<\/jats:sup> persons with oral warts or OHL and lesion\u2010negative sites from HIV<jats:sup>+<\/jats:sup> persons who were oral HPV or EBV DNA\u2010positive (matched controls). Cytokine\/chemokine mRNA expression was quantified by real\u2010time polymerase chain reaction. CD3, CD4, and CD8 cells were identified by immunohistochemistry.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> No differences were detected in tissue\u2010associated cytokine\/chemokine mRNA expression in warts or OHL when compared to lesion\u2010negative sites. Immunohistochemical analysis of T cells showed CD8<jats:sup>+<\/jats:sup> cells exclusively, but few cells were present in either lesion. No differences were detected between lesion\u2010positive and \u2010negative control sites of each pathologic condition.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Little evidence was found for local immune reactivity to either oral warts and OHL, suggesting that CD4<jats:sup>+<\/jats:sup> T cells are a primary host defense against both oral warts and OHL, but with nonimmune factors potentially responsible for the divergent prevalence of each.<\/jats:p>","DOI":"10.1111\/j.1399-302x.2005.00198.x","type":"journal-article","created":{"date-parts":[[2005,4,11]],"date-time":"2005-04-11T09:36:34Z","timestamp":1113212194000},"page":"154-162","source":"Crossref","is-referenced-by-count":22,"title":["Lack of evidence for local immune activity in oral hairy leukoplakia and oral wart lesions"],"prefix":"10.1111","volume":"20","author":[{"given":"E. A.","family":"Lilly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. V.","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"Leigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. M.","family":"McNulty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cheeks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E.","family":"Hagensee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"P. L.","family":"Fidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,4,11]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1601-0825.2001.70108.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1998.tb01979.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/088282403763635401"},{"key":"e_1_2_6_5_2","unstructured":"CameronJE MercanteDE O'BrienM GaffgaAM LeighJE FidelPJr et al.The impact of highly active antiretroviral therapy (HAART) immunodeficiency human papillomavirus (HPV) on infection in the oral cavity of HIV seropositive adults. (in press)."},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0714.2002.310102.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2000.tb00320.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.1.357-361.2000"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04578-5"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)90872-9"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.3.475"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200009010-00006"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(92)90185-S"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198512193132502"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246047"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.9.3274-3279.2000"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1086\/338637"},{"key":"e_1_2_6_18_2","first-page":"7","article-title":"Oral warts rise dramatically with use of new agents in HIV","volume":"1","author":"Leigh JE","year":"2000","journal-title":"HIV Clin"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199812010-00008"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/422154"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-200104000-00005"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00826.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.2.956-963.2003"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.405"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1998.tb01916.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/383132"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0909-8836.1999.eos107401.x"}],"container-title":["Oral Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-302X.2005.00198.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-302X.2005.00198.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T03:59:56Z","timestamp":1696910396000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-302X.2005.00198.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,11]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1111\/j.1399-302X.2005.00198.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-302x.2005.00198.x","archive":["Portico"],"relation":{},"ISSN":["0902-0055","1399-302X"],"issn-type":[{"value":"0902-0055","type":"print"},{"value":"1399-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,11]]}}}